[Remote] Associate Medical Director at Natera

Remote

Natera Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, DiagnosticsIndustries

Skills

Key technologies and capabilities for this role

Molecular diagnosticsClinical developmentProtocol designClinical trial recruitmentProduct developmentTest interpretationCustomer supportMedical educationKOL engagementPublication strategyRegulatory inputPublic relations

Questions & Answers

Common questions about this position

Is this position remote?

Yes, this is a remote position.

What is the salary for the Associate Medical Director role?

This information is not specified in the job description.

What qualifications are required for this role?

Candidates must have an M.D. and/or Ph.D., at least 5 years of practice experience (post fellowship) in GI Oncology treating patients, knowledge of practice guidelines across GI cancer types, and at least 3 years of clinical trial experience.

What does the team structure look like for this role?

This will initially be an individual contributor role with an opportunity to build a team as the business grows.

What experience makes a strong candidate for this position?

Strong candidates will have at least 2 years’ experience in industry, Medical Affairs, or Clinical Development with a record of success in commercializing transplant products, in addition to the required qualifications.

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI